Author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627.
Yinong Young-XuRichard MelsheimerBruno EmondPatrick LefebvreMaral DerSarkissianAngela LaxCatherine NguyenRachel H BhakMelody WuIris LinPublished in: Current medical research and opinion (2022)
Keyphrases